Friday 6 November 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024.

Revenue: +36.3%
EPS: +36.0%
Free cash flow: +3.85%
Total debt: −26.6%

Quarter to September 2026, against a year earlier

905.02 2.12 +0.23%

Follow REGN

Alert me

Market cap: $93.4B
P/E: 19.2×
Fwd P/E: 19.2×
Dividend yield: 0.41%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	6	7
ROE Full definition →		14.87%	14.55%	14.04%	14.95%
ROA Full definition →		11.50%	11.28%	10.83%	11.39%
ROIC Full definition →		8.82%	9.20%	9.34%	11.61%
Return on Tangible Assets Full definition →		24.00%	24.08%	23.56%	23.71%
Average Days of Receivables Full definition →		146.10	140.21	154.26	163.72
Free Cash Flow per Share Full definition →		36.00	36.45	34.78	35.67
Free Cash Flow Full definition →		3,765.20	3,791.00	3,575.20	3,628.10
Capital Expenditures Full definition →		(1,213.70)	(1,221.70)	(1,106.10)	(1,217.90)
Other line items
Cash ROIC Full definition →		8.85%	8.99%	8.58%	8.10%
Accounts Receivable Turnover Full definition →		2.40	2.64	2.55	2.55
Accounts Payable Turnover Full definition →		2.43	2.66	2.50	2.35
Inventory Turnover Full definition →		0.67	0.73	0.75	0.78
Average Days of Payables Full definition →		163.15	162.59	179.90	173.12
Days of Inventory on Hand Full definition →		556.14	491.29	478.62	439.47
Tax Rate Full definition →		(0.14)	(0.14)	(0.16)	(0.15)
Research and Development Expense of Revenue Full definition →		40.79%	40.66%	40.40%	39.04%
Selling, General and Administrative Expense of Revenue Full definition →		18.82%	18.20%	17.65%	16.35%
Share Based Compensation of Revenue Full definition →		6.93%	6.67%	6.35%	5.95%
Interest Coverage Full definition →		81.69	75.61	69.37	104.16
Operating CF/Net income Full definition →		1.11	1.13	1.08	1.01
Depreciation/Fixed assets Full definition →		0.11	0.10	0.10	0.09
Capex/Depreciation Full definition →		(2.23)	(2.26)	(2.09)	(2.37)
Revenue per Share Full definition →		137.12	143.46	151.12	166.14
Operating CF per Share Full definition →		47.60	48.20	45.54	47.65
Capex per Share Full definition →		(11.60)	(11.75)	(10.76)	(11.98)
Capex to Sales Full definition →		0.08	0.08	0.07	0.07

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly